Business Description
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.83 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -13.82 | |||||
Beneish M-Score | -1.76 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -55.8 | |||||
3-Year EBITDA Growth Rate | 21.8 | |||||
3-Year EPS without NRI Growth Rate | 22.8 | |||||
3-Year FCF Growth Rate | 22.6 | |||||
3-Year Book Growth Rate | -44.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.06 | |||||
9-Day RSI | 51.15 | |||||
14-Day RSI | 47.86 | |||||
6-1 Month Momentum % | -49.18 | |||||
12-1 Month Momentum % | -79.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.53 | |||||
Quick Ratio | 4.75 | |||||
Cash Ratio | 4.37 | |||||
Days Inventory | 762.92 | |||||
Days Sales Outstanding | 133.17 | |||||
Days Payable | 126.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 21.58 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.66 | |||||
Operating Margin % | -763.17 | |||||
Net Margin % | -740.1 | |||||
FCF Margin % | -696.89 | |||||
ROE % | -85.23 | |||||
ROA % | -68.43 | |||||
ROIC % | -484.46 | |||||
ROC (Joel Greenblatt) % | -665.11 | |||||
ROCE % | -78.16 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2 | |||||
PB Ratio | 0.38 | |||||
Price-to-Tangible-Book | 0.38 | |||||
EV-to-EBIT | 0.37 | |||||
EV-to-EBITDA | 0.39 | |||||
EV-to-Revenue | -2.71 | |||||
EV-to-FCF | 0.4 | |||||
Price-to-Net-Current-Asset-Value | 0.44 | |||||
Price-to-Net-Cash | 0.62 | |||||
Earnings Yield (Greenblatt) % | 268.92 | |||||
FCF Yield % | -346.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Human Xtensions Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 4.95 | ||
EPS (TTM) (₪) | -1.37 | ||
Beta | 0 | ||
Volatility % | 66.9 | ||
14-Day RSI | 47.86 | ||
14-Day ATR (₪) | 0.031067 | ||
20-Day SMA (₪) | 0.36405 | ||
12-1 Month Momentum % | -79.46 | ||
52-Week Range (₪) | 0.317 - 2.5 | ||
Shares Outstanding (Mil) | 26.76 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Human Xtensions Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Human Xtensions Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Human Xtensions Ltd Frequently Asked Questions
What is Human Xtensions Ltd(XTAE:HUMX)'s stock price today?
When is next earnings date of Human Xtensions Ltd(XTAE:HUMX)?
Does Human Xtensions Ltd(XTAE:HUMX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |